Medical services

Pregnancy complications encompass a broad spectrum of health issues that can arise during gestation, impacting the well-being of both the mother and the developing fetus. These complications vary in severity and may include conditions such as gestational diabetes, preeclampsia, placenta previa, preterm labor, miscarriage, and fetal growth restriction. Factors such as maternal age, pre-existing health conditions, lifestyle choices, genetic predispositions, and environmental factors can contribute to their development. Early detection, proper medical management, and timely intervention are crucial in mitigating risks and ensuring optimal outcomes for both mother and baby. We believe that close monitoring by our dedicated healthcare professionals, strict adherence to prenatal care guidelines, and open communication between you, the expectant mother, and our healthcare team are crucial elements in effectively managing and addressing any pregnancy complications that may arise. Your health and the well-being of your baby are our top priorities, and we are committed to providing you with the highest quality care every step of the way.

Genetic counseling in high-risk pregnancies is an essential service that helps expectant parents understand the potential genetic conditions or abnormalities that could affect their baby. It involves a thorough evaluation of the family's medical history, genetic screening, and diagnostic tests to identify potential risks. Genetic counselors provide guidance on the implications of test results, helping parents make informed decisions about their pregnancy. For those with a history of genetic disorders, advanced maternal age, or other risk factors, genetic counseling offers valuable insights and support, ensuring the best possible care throughout the pregnancy.

If you currently have cancer, had cancer previously, or you’re at an increased risk of developing cancer during pregnancy, this affects your prenatal care. We discuss how to balance all aspects of your pregnancy and cancer diagnosis or risk to optimize your and your baby’s health. Our experienced team is well-equipped to help you navigate the complexities of managing both your cancer treatment and the health of your pregnancy. Through close monitoring, adherence to prenatal care guidelines, and open communication, we will work together to develop a personalized care plan that prioritizes both your well-being and the health of your baby. Your strength and resilience inspire us, and we are committed to providing you with the highest quality of care to ensure the best possible outcomes for you and your growing family.

Cardiovascular disease during pregnancy refers to any pre-existing or newly developed heart conditions that affect expectant mothers. These conditions may include but are not limited to, hypertension, congenital heart defects, valvular heart disease, arrhythmias, and cardiomyopathies. Pregnancy imposes significant physiological changes on the cardiovascular system, placing additional stress on the heart. As a result, women with pre-existing heart conditions may experience exacerbation of symptoms or complications during pregnancy. Proper management and close monitoring are essential to ensure the health and safety of both the mother and the developing fetus. Our team will work closely with pregnant individuals to develop personalized care plans, which may include medication management, lifestyle modifications, and specialized prenatal care, to optimize outcomes and minimize risks associated with cardiovascular disease during pregnancy. Early detection, timely intervention, and ongoing communication between the patient and our healthcare team are crucial for a successful pregnancy outcome.

Diabetes and other endocrine disorders in pregnancy encompass a range of conditions related to the endocrine system, such as diabetes mellitus, thyroid disorders, and adrenal gland disorders, that can affect pregnant individuals. Diabetes, including both type 1 and type 2 diabetes, presents unique challenges during pregnancy due to fluctuations in blood sugar levels and increased risk of complications for both the mother and baby. Similarly, thyroid disorders, such as hyperthyroidism or hypothyroidism, can impact maternal health and fetal development if not properly managed. Our team are experts in caring for women with diabetes and other endocrine disorders. Early detection, proactive management, and ongoing communication between you and our healthcare providers are critical components in navigating diabetes and other endocrine disorders in pregnancy.

Fetal abnormalities refer to structural or functional anomalies present in a developing fetus during pregnancy. These abnormalities can affect various organs, systems, or body parts, and may arise due to genetic factors, environmental exposures, or unknown causes. Common fetal abnormalities include congenital heart defects, neural tube defects, chromosomal abnormalities (such as Down syndrome), skeletal deformities, and abnormalities of the gastrointestinal or urinary systems. While some fetal abnormalities are minor and may not significantly impact the baby's health or development, others can pose serious risks and may require medical intervention or specialized care. We offer prenatal screening and diagnostic tests, such as ultrasound scans, amniocentesis, and genetic testing, which play a crucial role in detecting fetal abnormalities early in pregnancy, allowing us to offer appropriate counseling, monitoring, and interventions to optimize outcomes for both the baby and the expectant mother. Early detection and comprehensive prenatal care are essential in managing fetal abnormalities and supporting families through the pregnancy journey.

Genetic disorders in pregnancy encompass a broad spectrum of conditions caused by abnormalities in the genes, sometimes inherited from one or both parents. These disorders can range from chromosomal abnormalities, such as Down syndrome, to single gene disorders like cystic fibrosis or sickle cell anemia. Genetic disorders can have varying degrees of impact on the health and development of the fetus, ranging from mild to severe. We offer prenatal screening and diagnostic tests, including genetic counseling, carrier screening, and advanced genetic testing, which play a crucial role in identifying genetic disorders early in pregnancy. With early detection, we offer expectant parents personalized counseling and options for further testing, intervention, and management strategies. While genetic disorders can present challenges during pregnancy, advancements in medical technology and genetic research have enabled our healthcare team to provide comprehensive care and support to families facing these conditions, ultimately striving to optimize outcomes for both the baby and the expectant mother.

Diabetes and other endocrine disorders in pregnancy encompass a range of conditions related to the endocrine system, such as diabetes mellitus, thyroid disorders, and adrenal gland disorders, that can affect pregnant individuals. Diabetes, including both type 1 and type 2 diabetes, presents unique challenges during pregnancy due to fluctuations in blood sugar levels and increased risk of complications for both the mother and baby. Similarly, thyroid disorders, such as hyperthyroidism or hypothyroidism, can impact maternal health and fetal development if not properly managed. Our team are experts in caring for women with diabetes and other endocrine disorders. Early detection, proactive management, and ongoing communication between you and our healthcare providers are critical components in navigating diabetes and other endocrine disorders in pregnancy.

Multifetal pregnancies, also known as multiple pregnancies or pregnancies with more than one fetus, occur when a woman carries two or more babies simultaneously. These pregnancies can result from the release and fertilization of multiple eggs during ovulation (dizygotic or fraternal twins) or from the division of a single fertilized egg into two or more embryos (monozygotic or identical twins). Multifetal pregnancies can also involve triplets, quadruplets, or higher-order multiples. While multifetal pregnancies bring joy and excitement, they also present unique challenges and increased risks for both the mother and the babies. Complications associated with multifetal pregnancies include preterm birth, low birth weight, twin to twin transfusion syndrome, gestational diabetes, preeclampsia, placental abnormalities, and congenital anomalies. Our healthcare team ensures proper prenatal care, including close monitoring and specialized medical attention, which is essential to optimize outcomes for both the mother and the babies in multifetal pregnancies. We work closely with expectant parents to address any concerns, manage potential risks, and provide support throughout the pregnancy journey.

Placental problems encompass a range of conditions affecting the placenta, the vital organ that nourishes and supports the developing fetus during pregnancy. These problems can include placenta previa, where the placenta partially or completely covers the cervix, placental abruption, where the placenta detaches from the uterine wall prematurely, and placenta accreta, where the placenta attaches too deeply into the uterine wall. Placental problems can lead to complications such as vaginal bleeding, preterm birth, fetal growth restriction, and maternal hemorrhage. Our healthcare team focuses on timely detection and management of placental problems, which are crucial to minimizing risks and optimizing outcomes for both the mother and the baby. Close monitoring during prenatal care, along with appropriate medical interventions when necessary, play a key role in addressing placental problems and ensuring a healthy pregnancy.

Hypertension in pregnancy refers to high blood pressure that develops during gestation and can have significant implications for both the mother and the baby. This condition can manifest as either chronic hypertension, present before pregnancy or diagnosed before 20 weeks of gestation, or gestational hypertension, which arises after 20 weeks of pregnancy in previously normotensive women. Additionally, preeclampsia, a serious complication characterized by high blood pressure and signs of damage to other organ systems, can develop in women with or without pre-existing hypertension. Hypertension in pregnancy increases the risk of complications such as preterm birth, intrauterine growth restriction, placental abruption, and eclampsia, which can have severe consequences for both maternal and fetal health. Our healthcare team ensures close monitoring, timely intervention, and management of blood pressure levels are essential to mitigate risks and ensure the best possible outcomes for mother and baby.

Preeclampsia, also known as toxemia, is a serious pregnancy complication characterized by high blood pressure and signs of damage to other organ systems, typically occurring after 20 weeks of gestation. This condition can manifest as proteinuria (protein in the urine), kidney dysfunction, liver abnormalities, and blood clotting problems. Preeclampsia can progress to eclampsia, a life-threatening condition marked by seizures, which poses significant risks to both the mother and the baby. While the exact cause of preeclampsia is not fully understood, it is believed to involve abnormalities in the placenta, immune system, and blood vessels. Risk factors for preeclampsia include a history of the condition, first-time pregnancy, maternal age over 35, obesity, and certain medical conditions like diabetes and hypertension. Early detection through regular prenatal care and monitoring of blood pressure and urine protein levels is crucial in managing preeclampsia and preventing complications. Treatment may involve close monitoring, medications to lower blood pressure, and timely delivery of the baby in severe cases. Our healthcare team are experts in effectively managing preeclampsia and ensuring the health and safety of both mother and baby.

Cholestasis of pregnancy is a liver disorder characterized by decreased or blocked bile flow during pregnancy, leading to a buildup of bile acids in the bloodstream. This condition typically occurs in the second or third trimester and is associated with symptoms such as intense itching, particularly on the hands and feet. Cholestasis of pregnancy can increase the risk of complications for both the mother and the baby, including preterm birth, fetal distress, and stillbirth. While the exact cause is not fully understood, hormonal changes during pregnancy are thought to play a role in disrupting bile flow. Our healthcare team ensures close monitoring and management of cholestasis of pregnancy, which are essential to reduce the risk of complications. Treatment may involve medications to alleviate itching, monitoring fetal well-being through non-stress tests and ultrasound, and potentially early delivery if complications arise.

Preterm birth refers to the delivery of a baby before 37 weeks of gestation, instead of the typical 40-week duration of a full-term pregnancy. This occurrence can be spontaneous, resulting from factors such as premature labor or preterm rupture of membranes, or medically indicated due to maternal or fetal health concerns. Preterm birth poses significant risks to the health and development of the baby, as premature infants may have immature organ systems and are more vulnerable to complications such as respiratory distress syndrome, feeding difficulties, jaundice, and neurological issues. Additionally, preterm birth can also increase the risk of long-term health problems and developmental delays. We closely monitor pregnancies to identify and manage risk factors associated with preterm birth, such as multiple gestations, maternal health conditions like hypertension or diabetes, infections, and lifestyle factors like smoking or substance abuse. Early detection, timely intervention, and specialized neonatal care are essential in improving outcomes for preterm infants and reducing the potential for long-term complications.

Cerclage placement is a surgical procedure performed during pregnancy to reinforce the cervix and prevent it from opening prematurely. This procedure is typically recommended for women who have a history of cervical insufficiency or have experienced previous preterm births due to cervical weakness. During cerclage placement, a stitch or band is placed around the cervix to provide mechanical support and help maintain its integrity throughout the remainder of the pregnancy. Cerclage placement is usually performed between weeks 12 and 24 of gestation, depending on individual circumstances. The goal of cerclage placement is to reduce the risk of cervical dilation and premature delivery, thus improving the chances of carrying the pregnancy to term and reducing the potential for complications associated with preterm birth. Our team of healthcare providers will work closely with you during this time, which is essential after cerclage placement to ensure the cervix remains stable and the pregnancy progresses safely.

Cephalic version is a medical procedure performed during pregnancy to manually reposition a breech or transverse fetus into a head-down, or cephalic, position within the uterus. Typically attempted during the late third trimester, cephalic version is often recommended for women whose babies remain in a breech or transverse presentation close to term. During the procedure, our team of healthcare providers use gentle pressure on the mother's abdomen to encourage the fetus to rotate into the desired position. Cephalic version is typically conducted under ultrasound guidance to ensure the safety of both the mother and the baby. By facilitating the optimal positioning of the fetus before labor begins, cephalic version can increase the likelihood of a vaginal delivery and reduce the need for a cesarean section, which may be necessary if the baby remains in a breech or transverse position. Close monitoring before, during, and after the procedure is essential to assess fetal well-being and ensure the success of the version attempt.

Growth problems in pregnancy refer to conditions where the fetus does not develop at the expected rate or does not reach the anticipated size for its gestational age. These issues can manifest as either fetal growth restriction (FGR), where the fetus fails to achieve its genetic growth potential, or macrosomia, where the fetus grows larger than expected. FGR may result from various factors such as placental insufficiency, maternal health conditions like hypertension or diabetes, infections, smoking, or nutritional deficiencies. Conversely, macrosomia is often associated with maternal diabetes, excessive maternal weight gain, or genetic factors. Both FGR and macrosomia can pose risks during pregnancy and childbirth, including an increased likelihood of complications such as preterm birth, cesarean delivery, or neonatal complications. Early detection through regular prenatal monitoring, including ultrasound scans to assess fetal growth, is essential in identifying growth problems and implementing appropriate management strategies to optimize outcomes for both the mother and the baby.

Allo-immunization in pregnancy occurs when a pregnant woman's immune system produces antibodies that target antigens on the red blood cells of her fetus. This typically happens when there is a mismatch between the blood types of the mother and baby, such as when the mother is Rh-negative and the baby is Rh-positive. Allo-immunization can also occur in other blood group systems, such as the Kell, Duffy, or Kidd systems. When these antibodies cross the placenta, they can lead to hemolytic disease of the fetus and newborn (HDFN), a condition characterized by the destruction of the fetus's red blood cells, which can cause anemia, jaundice, and other complications. To prevent HDFN, Rh-negative women are often given Rh immunoglobulin (RhIg) during pregnancy and after delivery to prevent the development of Rh antibodies. Our team of healthcare providers offer close monitoring and specialized care that are essential for pregnant women at risk of allo-immunization to minimize the risk of complications for both the mother and the baby.

Non-stress testing (NST) is a prenatal monitoring technique used to assess the well-being of the fetus during pregnancy. Typically performed in the third trimester, NST involves the use of external monitors to track fetal heart rate patterns and uterine contractions over a period of time, usually 20-30 minutes. During the test, fetal heart rate accelerations in response to fetal movement are considered reassuring, indicating that the baby's central nervous system is functioning properly and receiving adequate oxygenation. NST is often recommended for pregnant women with high-risk factors, such as gestational diabetes, hypertension, or decreased fetal movement, to evaluate fetal health and detect any signs of distress. A non-reactive NST, where fetal heart rate accelerations are not observed, may prompt further evaluation or additional testing to ensure the well-being of the fetus. Non-stress testing is a safe and non-invasive procedure that plays a valuable role in prenatal care, helping our team of healthcare providers monitor fetal health and make informed decisions to optimize outcomes for both mother and baby.